Filter
471
Text search:
adverse
drug
event
Featured
Recommendations
65
New Publications
103
Language
Document type
No document type
255
Guidelines
86
Studies & Reports
66
Manuals
29
Strategic & Response Plan
15
Fact sheets
8
Training Material
6
Situation Updates
3
App
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
28
Western and Central Europe
23
Global
14
South Africa
13
Latin America and the Carribbean
11
Ethiopia
10
Eastern Europe
10
Nigeria
9
Uganda
9
Kenya
9
Africa
9
Ghana
8
Syria
5
Bangladesh
5
Philippines
4
Nepal
4
Tanzania
4
Rwanda
4
South–East Asia Region
4
Liberia
3
USA
3
Zimbabwe
3
Cambodia
3
Malawi
3
Namibia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Sierra Leone
2
Lesotho
2
West and Central Africa
2
Asia
2
Tajikistan
2
Congo, Democratic Republic of
1
Cameroon
1
South Sudan
1
Iraq
1
Zambia
1
China
1
Mozambique
1
Argentina
1
Eswatini/ Swaziland
1
North Macedonia
1
Ukraine
1
Botswana
1
East and Southern Africa
1
Western Pacific Region
1
Bhutan
1
Timor Leste/ East Timor
1
Russia
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
74
Public Health
27
Women & Child Health
25
Key Resources
15
Pharmacy & Technologies
12
Capacity Building
8
Toolboxes
TB
56
Mental Health
50
HIV
44
COVID-19
31
Pharmacy
23
AMR
17
Caregiver
16
NTDs
16
NCDs
10
Ebola & Marburg
9
Rapid Response
9
Planetary Health
9
Conflict
7
Specific Hazards
7
Malaria
6
Natural Hazards
5
Refugee
5
2.0 Rapid Response
5
Disability
4
Polio
4
Global Health Education
4
Cholera
2
Zika
1
Social Ethics
1
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Surveillance Report
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
8–18 December 2015
The World Health Organization (WHO) is releasing the second edition of its Global Accelerated Action for the Health of Adolescents (AA-HA!) guidance. The document aims to equip governments to respond to the health and well-being challenges, opportunities and needs of adolescents.
The guidance pro
...
This study aimed to estimate the proportion of Mozambicans eligible for pharmacological treatment for hypertension according to single risk factor and total cardiovascular risk approaches. It concluded that a total of 19.8% of 40–64-year-olds would be eligible for pharmacological treatment of hype
...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in
...
WHO mhGAP Guideline update
recommended
Update of the Mental Health Gap Action Programme
(mhGAP) Guideline for Mental, Neurological and Substance use Disorders May 2015
Towards the Peoples Health Assembly Book - 5
WHO recommendations on child health: Guidelines approved by the WHO Guidelines Review Committee
recommended
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should the child receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv
...